Cargando…

MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS

BACKGROUND: Despite increased risk of comorbidities, overweight may be associated with improved outcome in patients with metastatic cancer. Conversely, tumor cachexia has been identified as a negative predictor of outcome in patients with brain metastasis (BM) from lung cancer. Here we evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Michael, Lareida, Anna, Terziev, Robert, Grossenbacher, Bettina, Andratschke, Nicolaus, Roth, Patrick, Rohrmann, Sabine, Stahel, Rolf, Guckenberger, Matthias, Le Rhun, Emilie, Wolpert, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213465/ http://dx.doi.org/10.1093/noajnl/vdz014.068

Ejemplares similares

MLTI-19. VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH BRAIN METASTASES: THE PICOS SCORE
por: Wolpert, Fabian, et al.
Publicado: (2019)

MLTI-13. RESPONSE ASSESSMENT OF MELANOMA BRAIN METASTASES TREATED BY STEREOTACTIC RADIOTHERAPY OR IMMUNOTHERAPY OR BOTH: A COMPARISON OF RECIST 1.1, RANO AND iRANO CRITERIA
por: Le Rhun, Emilie, et al.
Publicado: (2019)

24. LOCAL TUMOR PROGRESSION IS A RISK FACTOR FOR POSTOPERATIVE SEIZURES IN PATIENTS WITH BRAIN METASTASIS
por: Grossenbacher, Bettina, et al.
Publicado: (2020)

Prognostic assessment in patients operated for brain metastasis from systemic tumors
por: Grossenbacher, Bettina, et al.
Publicado: (2023)

Postoperative progression of brain metastasis is associated with seizures
por: Wolpert, Fabian, et al.
Publicado: (2022)

Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Heavy Smoking Is More Strongly Associated with General Unhealthy Lifestyle than Obesity and Underweight
por: Lohse, Tina, et al.
Publicado: (2016)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

MLTI-08. AN EXCEPTIONAL INTRACRANIAL RESPONSE TO REPEAT RADIATION AND IMMUNOTHERAPY IN A PATIENT WITH METASTATIC, POORLY DIFFERENTIATED ADENOCARCINOMA OF THE LUNG
por: Sumrall, Ashley, et al.
Publicado: (2019)

MLTI-03. The relevance of the count of brain metastases for treatment and outcome in NSCLC
por: Reinecke, David, et al.
Publicado: (2021)

MLTI-04. The Role of the Outpatient Registered Nurse in the care of Brain Metastases
por: Hernandez, Juliana, et al.
Publicado: (2021)

MLTI-11. IMPLANTABLE POLYMERIC BCNU AS AN ADJUNCT TO SURGERY FOR METASTATIC INTRACRANIAL DISEASE
por: Ryken, Timothy, et al.
Publicado: (2019)

Mortality risk associated with underweight: a census-linked cohort of 31,578 individuals with up to 32 years of follow-up
por: Roh, Lucienne, et al.
Publicado: (2014)

40. AN UPDATE ON THE DEVELOPMENT OF A NEW TOOL TO ASSESS RESPONSE IN LEPTOMENINGEAL METASTASIS
por: Weller, Michael, et al.
Publicado: (2020)

Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
por: Le Rhun, Emilie, et al.
Publicado: (2020)

MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
por: Hong, Christopher, et al.
Publicado: (2019)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

MLTI-01. IMMUNOLOGICAL REPROGRAMMING IN THE CNS TUMOR MICROENVIRONMENT AND THERAPEUTIC EFFICACY OF RADIOTHERAPY WITH STAT3 BLOCKADE
por: Ott, Martina, et al.
Publicado: (2019)

MLTI-15. A CASE SERIES OF PRE-OPERATIVE GAMMA-KNIFE RADIOSURGERY FOR RESECTABLE BRAIN METASTASES
por: Takezaki, Tatsuya, et al.
Publicado: (2019)

MLTI-07. PREOPERATIVE VERSUS POSTOPERATIVE STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES: AN INTERNATIONAL META-ANALYSIS
por: Garcia, Henry Ruiz, et al.
Publicado: (2019)

MLTI-16. SYSTEMIC THERAPY FOLLOWING CRANIOTOMY IN PATIENTS WITH A SOLITARY BREAST CANCER BRAIN METASTASIS
por: Hulsbergen, Alexander, et al.
Publicado: (2019)

MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
por: Wilcox, Jessica, et al.
Publicado: (2021)

Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

MLTI-10. ESTABLISHMENT OF A MULTIDISCIPLINARY BRAIN METASTASIS CLINIC TO FACILITATE PATIENT-CENTERED CARE AND COORDINATED RESEARCH
por: Li, Jing, et al.
Publicado: (2019)

MLTI-14. A SYSTEMATIC REVIEW OF TREATMENT PARADIGMS FOR PATIENTS WITH BREAST CANCER AND ONE OR MORE BRAIN METASTASES
por: Ellenbogen, Yosef, et al.
Publicado: (2019)

Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology
por: Kraft, Johannes, et al.
Publicado: (2021)

Association of Underweight and Weight Loss With Poor Prognosis and Poor Therapy Effectiveness in Brain Metastases: A Retrospective Study
por: He, Yan, et al.
Publicado: (2022)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

MLTI-12. TIMING OF SYSTEMIC THERAPY ADMINISTRATION RELATIVE TO STEREOTACTIC RADIOSURGERY AND DEVELOPMENT OF RADIATION NECROSIS IN PATIENTS WITH BRAIN METASTASES
por: Hammoudeh, Lubna, et al.
Publicado: (2019)

Health Risk and Underweight
por: Cuntz, Ulrich, et al.
Publicado: (2023)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
por: Christ, Sebastian M., et al.
Publicado: (2022)

Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study
por: Saltybaeva, Natalia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gj0j1jdddi5mscm4b6j48uj44